The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 799 Mounjaro articles
A closer look at the groundbreaking GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, and their transformative effects on weight management and overall health.
Melanie Sivier shares her remarkable 9-stone weight loss journey, opting for a dedicated lifestyle change over medical interventions like gastric bands and newer GLP-1 agonists.
The phenomenon of 'food noise'—the constant internal monologue about what, when, and how much to eat—has become a central topic in the age of powerful weight management medications. While GLP-1 agonists are highly effective at dampening this chatter, lasting control often requires integrating behavioral and nutritional strategies. This article explores what food noise is, how medications impact it, and provides a comprehensive guide to regaining mental freedom over your eating habits.
While GLP-1 medications show promise for adult obesity, their use in children is raising significant concerns. A medical expert weighs in on the potential dangers and the critical need for specialist oversight.
From celebrity endorsements to GLP-1 weight loss drugs, peptides are everywhere. But what exactly are they, and can they deliver on their promises for skin health, longevity, and more? This article dives into the science, the trends, and the risks.
Curious about how long Ozempic, Wegovy, Mounjaro, or other GLP-1 medications stay in your system after your last dose? This comprehensive guide explores the science behind their elimination and what factors influence their duration.
The UK's MHRA has approved Wegovy (semaglutide) for treating MASH, a significant step forward for patients with metabolic-associated steatohepatitis and liver fibrosis. This article delves into the details of this approval, the drug's mechanism, and its implications.
Discover how GLP-1 medications are impacting more than just physical health, influencing career opportunities and personal relationships for women in a remarkable new study.
For years, Medicare coverage for GLP-1 medications like Ozempic and Wegovy was strictly limited to diabetes management. A significant shift is underway, however, as a new 'Bridge' program opens doors for weight loss coverage, albeit with specific requirements and nuances that patients must navigate.
